fda glp 1 shortage semaglutide status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list GLP-1 No Longer on FDA's – Is the GLP-1 compounding boom

Insulin-like growth factors in the fed and fasted states

The egregiously high list prices set by drug manufacturers of GLP-1s for weight loss are the single biggest barrier to patient access, CVS Health said in a statement

Protective effects of D,L-carnitine against arrhythmias induced by lysophosphatidylcholine or reperfusion

Amidst this, cosmetic treatments, particularly Glutathione IV injection, have gained popularity as a trusted option for enhancing skin radiance and achieving a more even complexion

While Victoza is not a weight loss medication, a study found that adults lost an average of up to 6.2 pounds when Victoza was used with metformin, another prescription medication for type 2 diabetes